PBPK modelling for quantitative in vitro-in vivo extrapolation
This record is part of
a dataset collected by the EU Commission in June-September 2018
. Some of these links will therefore die out with time.
Please see the
overview of courses maintained by ETPLAS
or contact Norecopa for more information.
Owner/Developer: Altertox Academy
|Description:||Physiology-based (pharmaco)kinetic PB(P)K modelling has become a promising tool to predict plasma and/or tissue exposure to xenobiotics based on in vitro disposition data. While physiological parameters that characterize the target population have been largely implemented in several PB(P)K platforms, further consensus building is needed with respect to the quality requirements of in vitro data used for a successful bottom-up modelling approach. Therefore, this workshop will focus on improved integration of in vitro drug disposition assessments with the latest developments in the field of PB(P)K-based prediction. Special attention will also be given to prediction of (tissue) partition coefficients.|
Hands-on training, Lecture, Webinars
Optional / Voluntary
Students, Researchers, Regulators and policy-makers, Teachers and educators, Technicians, Managers, Scientific officers / Project managers, Professionals (e.g. veterinarians)
Academia, Industry, Governmental bodies, Contract Research Organizations (CROs), Consulting, SMEs
Technical College, Undergraduate, University (Bachelor), University (Master), University (Doctoral education), Postdoctoral (teaching and research), Continuing Professional Development
Full coverage (a dedicated course)
|Details on the topic or technology covered:||
General Introduction to PBPK models
PBPK modelling equations, model input and software
Inclusion of the partition coefficients and metabolic clearance data from the day before in the PBPK model in Berkeley Madonna, evaluation of the model performance and use of the model for QIVIVE of toxicity data.
Inclusion of the data in Simcyp and comparison with the outcomes of Berkeley Madonna.
Drug-drug interaction Population (DNT)
Directive 2010/63/EU or equivalent
Understand new toxicological models
Practice side-by-side with the experts
Integrate and transfer these tools in your daily working environment or your future job
Increase your expertise on the regulatory context of REACH, Cosmetics ban, the EU Pharmacopoeia etc..
Discover new aspects and develop your skills for continuous education
|Accreditation body and/or authority that approved the education or training:||
The French Society of Toxicology (SFT)
Certificate of participation
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.